Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Central Nervous System Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00387920
What this trial is testing

Sunitinib in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Central Nervous System MetastasesChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Embryonal Tumor+7 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Ended earlyNCT02332889
What this trial is testing

Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs

Who this might be right for
GliomasMedulloblastomaNeuroectodermal Tumors, Primitive
University of Louisville 1
Early research (Phase 1)Not Yet RecruitingNCT07331064
What this trial is testing

Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid Rhabdoid Tumor

Who this might be right for
High Grade GliomasAtypical Teratoid Rhabdoid Tumors (ATRT)Diffuse Midline Glioma+2 more
Sarah Rumler 15
Testing effectiveness (Phase 2)Study completedNCT01956695
What this trial is testing

Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma

Who this might be right for
LymphomaRelapse
Institut Curie 45
Testing effectiveness (Phase 2)Study completedNCT00003234
What this trial is testing

Vinorelbine in Treating Children With Recurrent or Refractory Cancers

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastomaSarcoma
Children's Oncology Group 50
Early research (Phase 1)Ended earlyNCT00629187
What this trial is testing

Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) Malignancy

Who this might be right for
Central Nervous System NeoplasmsNeoplasm Metastasis
Tufts Medical Center 2
Early research (Phase 1)Active Not RecruitingNCT03598244
What this trial is testing

Savolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors

Who this might be right for
Recurrent Diffuse Intrinsic Pontine GliomaRecurrent Malignant GliomaRecurrent Medulloblastoma+5 more
National Cancer Institute (NCI) 41
Early research (Phase 1)Looking for participantsNCT06840886
What this trial is testing

PHST001 in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsOvarian CancerEndometrial Cancer+2 more
Pheast Therapeutics 272
Not applicableEnded earlyNCT00952185
What this trial is testing

Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more
City of Hope Medical Center 9
Early research (Phase 1)WithdrawnNCT00836628
What this trial is testing

Study of Busulfan for Refractory Central Nervous System (CNS) Tumors

Who this might be right for
Refractory Brain Tumors
Ann & Robert H Lurie Children's Hospital of Chicago
Early research (Phase 1)Study completedNCT01222780
What this trial is testing

To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer

Who this might be right for
SarcomaNeuroblastomaWilms Tumor+3 more
Acrotech Biopharma Inc. 22
Testing effectiveness (Phase 2)UnknownNCT03356769
What this trial is testing

Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex

Who this might be right for
Tuberous Sclerosis ComplexAspirinEpilepsy+2 more
Peking Union Medical College Hospital 98
Early research (Phase 1)Study completedNCT00098761
What this trial is testing

VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 42
Early research (Phase 1)WithdrawnNCT01182883
What this trial is testing

A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Brain Stem NeoplasmsGliomaPinealoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT01535183
What this trial is testing

Irinotecan Combination Chemotherapy for Refractory or Relapsed Brain Tumor in Children and Adolescents

Who this might be right for
Brain Tumor
Seoul National University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00407433
What this trial is testing

Clinical Studies of Gemcitabine-Oxaliplatin

Who this might be right for
MedulloblastomaCentral Nervous System TumorsNeuroblastoma+1 more
Gustave Roussy, Cancer Campus, Grand Paris 156
Large-scale testing (Phase 3)Active Not RecruitingNCT02962414
What this trial is testing

Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment

Who this might be right for
Tuberous Sclerosis Complex
Novartis Pharmaceuticals 206
Testing effectiveness (Phase 2)Study completedNCT00213278
What this trial is testing

Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma

Who this might be right for
Glioma
The Hospital for Sick Children 50
Early research (Phase 1)Study completedNCT00001565
What this trial is testing

Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy

Who this might be right for
Brain NeoplasmsNeuroblastoma
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Looking for participantsNCT04870944
What this trial is testing

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Who this might be right for
Diffuse Midline Glioma, H3 K27-AlteredMetastatic Malignant Neoplasm in the Central Nervous SystemRecurrent Diffuse Intrinsic Pontine Glioma+7 more
Children's Oncology Group 63
Next Page